These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32054539)

  • 1. Antimicrobial use among adult inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program: 2009 to 2016.
    Rudnick W; Science M; Thirion DJG; Abdesselam K; Choi KB; Pelude L; Amaratunga K; Comeau JL; Dalton B; Delport J; Dhami R; Embree J; Émond Y; Evans G; Frenette C; Fryters S; German G; Grant JM; Happe J; Katz K; Kibsey P; Kosar J; Langley JM; Lee BE; Lefebvre MA; Leis JA; McGeer A; Neville HL; Simor A; Slayter K; Suh KN; Tse-Chang A; Weiss K; Conly J;
    Antimicrob Resist Infect Control; 2020 Feb; 9(1):32. PubMed ID: 32054539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial use among paediatric inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program, 2017/2018.
    Rudnick W; Conly J; Thirion DJG; Choi K; Pelude L; Cayen J; Bautista J; Beique L; Comeau JL; Dalton B; Delport J; Dhami R; Embree J; Émond Y; Evans G; Frenette C; Fryters S; Happe J; Katz K; Kibsey P; Langley JM; Lee BE; Lefebvre MA; Leis JA; McGeer A; McKenna S; Neville HL; Slayter K; Suh KN; Tse-Chang A; Weiss K; Science M;
    Antimicrob Resist Infect Control; 2023 Apr; 12(1):35. PubMed ID: 37072874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic Guidelines for Critically Ill Patients in Nigeria.
    Oladele RO; Ettu AO; Medugu N; Habib A; Egbagbe E; Osinaike T; Makanjuola OB; Ogunbosi B; Irowa OO; Ejembi J; Uwaezuoke NS; Adeleke G; Mutiu B; Ogunsola F; Rotimi V
    West Afr J Med; 2023 Sep; 40(9):962-972. PubMed ID: 37768104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2018 Global Point Prevalence Survey of antimicrobial consumption and resistance in 47 Canadian hospitals: a cross-sectional survey.
    German GJ; Frenette C; Caissy JA; Grant J; Lefebvre MA; Mertz D; Lutes S; McGeer A; Roberts J; Afra K; Valiquette L; Émond Y; Carrier M; Lauzon-Laurin A; Nguyen TT; Al-Bachari H; Kosar J; Peermohamed S; Science M; Landry D; MacLaggan T; Daley P; McDonald G; Ang A; Chang S; Lin YC; Tong B; Malfair S; Leung V; Katz K; Pauwels I; Goossens H; Versporten A; Conly J; Thirion DJG
    CMAJ Open; 2021; 9(4):E1242-E1251. PubMed ID: 34933882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial use and antimicrobial resistance trends in Canada: 2014.
    Ebrahim M; Gravel D; Thabet C; Abdesselam K; Paramalingam S; Hyson C
    Can Commun Dis Rep; 2016 Nov; 42(11):227-231. PubMed ID: 29769991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of systemic antibacterial agents at a university emergency clinic in Bucharest, in the year 2008].
    Ion-Nedelcu N; Radu L; Firulescu S; Truţă E; Sîrbu M; Barbu G; Calistru P
    Bacteriol Virusol Parazitol Epidemiol; 2009; 54(1):53-8. PubMed ID: 20524396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
    Hsueh PR; Chen WH; Luh KT
    Int J Antimicrob Agents; 2005 Dec; 26(6):463-72. PubMed ID: 16280243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial defined daily dose in neonatal population.
    Villanueva-Bueno C; Montecatine-Alonso E; Jiménez-Parrilla F; Fernández-Llamazares CM; Manrique-Rodríguez S; Zamora-Flores E; Dolz E; Fernández-Polo A; Catillo-Salinas F; Comuñas J; Gallego-Fernández C; González-López M; Gómez-Trevecedo Calvo MT; Gázquez-Pérez R; Álvarez Del Vayo-Benito C; Gil-Navarro MV;
    Enferm Infecc Microbiol Clin (Engl Ed); 2022 Feb; 40(2):59-65. PubMed ID: 35120651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial use trends, Israel, 2012 to 2017.
    Dickstein Y; Temkin E; Ben-David D; Carmeli Y; Schwaber MJ
    Euro Surveill; 2019 Aug; 24(34):. PubMed ID: 31456558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2017 global point prevalence survey of antimicrobial consumption and resistance in Canadian hospitals.
    Frenette C; Sperlea D; German GJ; Afra K; Boswell J; Chang S; Goossens H; Grant J; Lefebvre MA; McGeer A; Mertz D; Science M; Versporten A; Thirion DJG
    Antimicrob Resist Infect Control; 2020 Jul; 9(1):104. PubMed ID: 32653046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial consumption at Auckland City Hospital: 2006-2009.
    Ticehurst R; Thomast M
    N Z Med J; 2011 Apr; 124(1332):9-20. PubMed ID: 21747419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Healthcare-Associated Infections and Antimicrobial Use Among Adult Inpatients in Singapore Acute-Care Hospitals: Results From the First National Point Prevalence Survey.
    Cai Y; Venkatachalam I; Tee NW; Tan TY; Kurup A; Wong SY; Low CY; Wang Y; Lee W; Liew YX; Ang B; Lye DC; Chow A; Ling ML; Oh HM; Cuvin CA; Ooi ST; Pada SK; Lim CH; Tan JWC; Chew KL; Nguyen VH; Fisher DA; Goossens H; Kwa AL; Tambyah PA; Hsu LY; Marimuthu K
    Clin Infect Dis; 2017 May; 64(suppl_2):S61-S67. PubMed ID: 28475790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic use in adult outpatients in Switzerland in relation to regions, seasonality and point of care tests.
    Achermann R; Suter K; Kronenberg A; Gyger P; Mühlemann K; Zimmerli W; Bucher HC
    Clin Microbiol Infect; 2011 Jun; 17(6):855-61. PubMed ID: 20731682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage.
    McKinnell JA; Kunz DF; Chamot E; Patel M; Shirley RM; Moser SA; Baddley JW; Pappas PG; Miller LG
    Infect Control Hosp Epidemiol; 2012 Jul; 33(7):718-24. PubMed ID: 22669234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram.
    Cook PP; Catrou PG; Christie JD; Young PD; Polk RE
    J Antimicrob Chemother; 2004 May; 53(5):853-9. PubMed ID: 15044426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of antimicrobial stewardship program implementation at four tertiary private hospitals: results of a five-years pre-post analysis.
    Al-Omari A; Al Mutair A; Alhumaid S; Salih S; Alanazi A; Albarsan H; Abourayan M; Al Subaie M
    Antimicrob Resist Infect Control; 2020 Jun; 9(1):95. PubMed ID: 32600391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of Japan's National Action Plan on Antimicrobial Resistance on antimicrobial use.
    Kusama Y; Tsuzuki S; Muraki Y; Koizumi R; Ishikane M; Ohmagari N
    Int J Infect Dis; 2021 Feb; 103():154-156. PubMed ID: 33227519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of 27 parenteral antimicrobial agents in north of France hospitals.
    Alfandari S; Bonenfant C; Depretere L; Beaucaire G;
    Med Mal Infect; 2007 Feb; 37(2):103-7. PubMed ID: 17303361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings.
    Aldeyab MA; Harbarth S; Vernaz N; Kearney MP; Scott MG; Darwish Elhajji FW; Aldiab MA; McElnay JC
    Br J Clin Pharmacol; 2012 Jul; 74(1):171-9. PubMed ID: 22150975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial consumption in five adult intensive care units: a 33-month surveillance study.
    Balkhy HH; El-Saed A; El-Metwally A; Arabi YM; Aljohany SM; Al Zaibag M; Baharoon S; Alothman AF
    Antimicrob Resist Infect Control; 2018; 7():156. PubMed ID: 30598819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.